| Financial Year |
March 31 2023 |
| Monetary Funds |
614,042,338.83 |
| Held-for-trading Financial Assets |
34,061,945.40 |
| Notes Receivable |
10,984,520.92 |
| Accounts Receivable |
581,675,016.20 |
| Advances to Suppliers |
30,753,357.06 |
| Other Receivables |
44,957,526.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
490,177,452.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,512,577.11 |
| Total Current Assets |
1,900,642,916.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
25,664,256.79 |
| Long-term Equity Investment |
193,286,991.69 |
| Investment Properties |
94,139,283.75 |
| Fixed Assetes |
212,566,559.36 |
| Under-construction Projects |
43,625,140.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,913,321.79 |
| R&D expenses |
5,382,101.09 |
| Goodwill |
4,181,796.25 |
| Long-Term Deferred and Prepaid Expenses |
3,170,190.44 |
| Deferred Income Tax Assets |
37,830,528.61 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
738,304,570.53 |
| Total Assets |
2,638,947,487.11 |
| Short-Term Loans |
31,014,697.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
69,938,716.87 |
| Accounts Payable |
420,810,350.40 |
| Accounts Received In Advance |
68,600.00 |
| Employee Compensation Payable |
12,577,820.44 |
| Taxes Payable |
1,165,486.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,111,016.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,001,645.41 |
| Other Current Liabilities |
3,546,969.71 |
| Sub-Total of Current Liabilities |
715,702,897.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
112,980,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,322,464.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
118,138,881.04 |
| Total Liabilities |
833,841,778.91 |
| Paid-In Capital(Or Share Stock) |
410,245,949.00 |
| Capital Surplus |
1,040,295,372.27 |
| Surplus Reserve |
66,028,081.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
209,413,293.59 |
| Minority Stockholder's Interest |
79,123,012.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,725,982,696.18 |
| Owner's Equity（Stockholder's Equity） |
1,805,105,708.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,638,947,487.11 |
